Company Profile

Establish an excellent pharmaceutical brand and become a century-old health industry

--HOLWRAY PHARMACEUTICAL (CHINA) COMPANY LIMITED: Striving Ahead

Located in the high-tech industrial park of Meihekou, a national civilized city in Jilin Province, HOLWRAY PHARMACEUTICAL (CHINA) COMPANY LIMITED is a modern pharmaceutical enterprise integrating research, production and sales of chemical drugs and Chinese patent medicine. It was established in 2011 with a registered capital of 146.8 million yuan. The park covers an area of more than 300,000 square meters and has more than 25,000 square meters of production workshops and supporting facilities. It officially passed GMP certification and put into production in February 2012.

The Company mainly produces solid preparations, its products cover tablets, hard capsules and granules, and its therapeutic area involves digestive system, cardiovascular and cerebrovascular system, respiratory system and other fields. And we have 3 GMP production lines and 10 independent property rights with drug approval. Our main product is Compound Bismuth and Magnesium Granules, which is made to treat acute and chronic gastritis, duodenal ulcer, reflux esophagitis, neurotic dyspepsia and gastric discomfort symptoms related to gastric acid; besides, it can also be used to treat stomachache, stomach distension, gastro spasm and the like caused by other reasons, and to prevent gastric mucosal injury induced by non-steroidal drugs. As the Company's exclusive product with independent intellectual property rights, it has won high praise from consumers since it was launched and has now been sold well domestically.

The Company vigorously implements The Pharmaceutical Administration Law of the People's Republic of China, strictly abides by GMP standards, and performs a perfect quality control system to ensure the high quality of drugs.

The Company pays attention to the development and actual transformation and production of drugs with independent intellectual property rights. It has carried out extensive cooperation with Northeast Normal University, Beijing Branch of Chinese Medical Association, Peking University Health Science Center and other universities. Guided by traditional techniques, the Company has continuously improved its research and development level. With 10 domestic invention patents it has got, the Company is recognized as a national high-tech enterprise.

Adhering to the core values of "responsibility, innovation and excellence", the Company has established an innovation mechanism, developed innovation and transformed innovation achievements into products. It has been recognized as Meihekou City's "Enterprise Technology Center" by the Industry and Information Bureau of Meihekou City and won various innovation awards such as "Jilin Patent Award". Moreover, it has been rated as a "large taxpayer" of Meihekou City many times and made outstanding contributions to the local economy.

Being aware that the development of an enterprise is endless, HOLWRAY has always taken the vision of "building an excellent pharmaceutical brand and being a century-old health industry", and continuously improved the market-oriented, innovation-driven, quality-based business philosophy. With advanced technology, excellent team and high-quality brand image, we will continuously improve our core competitiveness and devote ourselves to building a new type of sustainable pharmaceutical enterprise--a garden-like factory with high scientific content, good economic benefits, low resource consumption and little environmental pollution.